Cordyceps Sunshine Biotech Holdings Valuation

Is RAJA.F undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

0/6

Valuation Score 0/6

Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of RAJA.F when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate RAJA.F's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate RAJA.F's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for RAJA.F?

Key metric: As RAJA.F barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.

The above table shows the Price to Book ratio for RAJA.F. This is calculated by dividing RAJA.F's market cap by their current book value.
What is RAJA.F's PB Ratio?
PB Ratio	-9738.6x
Book	-US$78.73k
Market Cap	US$666.72m

RAJA.F key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	756.2x
Enterprise Value/EBITDA	2365.5x
PEG Ratio	n/a

Price to Book Ratio vs Peers

How does RAJA.F's PB Ratio compare to its peers?

The above table shows the PB ratio for RAJA.F vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PB	Estimated Growth	Market Cap
Peer Average	4.5x
GLAS.F Glass House Brands	5.5x	n/a	US$552.3m
THRN Thorne HealthTech	3.6x	57.2%	US$550.6m
HNST Honest Company	6.2x	62.8%	US$840.0m
HKHC Horizon Kinetics Holding	2.7x	n/a	US$723.1m
RAJA.F Cordyceps Sunshine Biotech Holdings	n/a	n/a	US$666.7m

Price-To-Book vs Peers: RAJA.F has negative equity and a Price-To-Book Ratio (-9738.6x) compared to the peer average (4.8x).

Price to Book Ratio vs Industry

How does RAJA.F's PB Ratio compare vs other companies in the US Personal Products Industry?

8 Companies	Price / Book	Estimated Growth	Market Cap
NAII Natural Alternatives International	0.3x	n/a	US$25.38m
GRAM.F TPCO Holding	0.1x	n/a	US$19.07m
LIFD LFTD Partners	0.2x	n/a	US$6.86m
UPXI Upexi	0.2x	71.0%	US$4.77m

8 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Book vs Industry: RAJA.F has negative equity and a Price-To-Book Ratio (-9738.6x) compared to the US Personal Products industry average (2.7x).

Price to Book Ratio vs Fair Ratio

What is RAJA.F's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

RAJA.F PB Ratio vs Fair Ratio.
Fair Ratio
Current PB Ratio	-9738.6x
Fair PB Ratio	n/a

Price-To-Book vs Fair Ratio: Insufficient data to calculate RAJA.F's Price-To-Book Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Beauty Health

US$177.5m

Designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.

SKIN

US$1.47

-1.3%

-41.7%

Kimberly-Clark de México S. A. B. de C. V

Mex$86.2b

Manufactures, distributes, and sells disposable products in Mexico.

KCDM.F

Mex$1.37

0.4%

n/a

Shiseido Company

JP¥1.1t

Engages in the production and sale of cosmetics in Japan and internationally.

SSDO.F

JP¥19.60

-30.9%